PLYMOUTH MEETING, Pa., Nov. 11, 2026 /PRNewswire/ — INOVIO (NASDAQ: INO), a commercial-stage biotechnology company focused on developing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following investor conferences:
Jefferies Global Healthcare Conference in London
Date: Wednesday, November 18
Time: 12:00 p.m. EST / 5:00 p.m. GMT
Format: Presentation
Webcast: https://event.summitcast.com/view/avibSrFufLKeoLRAEgMxy6/e3gFZPzHNgoxtsxeAwXEr2
Piper Sandler 38th Annual Healthcare Conference in New York
Date: Tuesday, December 1
Time: 2:00-2:25 p.m. EST
Format: Fireside chat
Webcast: https://event.webcasts.com/starthere.jsp?ei=1782025&tp_key=9cacd40318
Replays of the presentations will be available for 90 days at the links above. During these conferences members of INOVIO’s management team will also be conducting one-on-one meetings with investors.
About INOVIO
INOVIO is a commercial-stage biotechnology company focused on developing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO’s technology optimizes the design and delivery of innovative DNA medicines that enable the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com and follow us on LinkedIn and X (formerly known as Twitter).
Contacts
Media: Josephine Galatioto – ICR Healthcare, inoviopr@icrhealthcare.com
Investors: Peter Vozzo – ICR Healthcare, (443) 213-0505, peter.vozzo@icrhealthcare.com
SOURCE INOVIO Pharmaceuticals, Inc.
